Key facts
- This page summarizes Eli Casdin's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2022, 18:05.
Eli Casdin - 17 Nov 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)
- Reporting relationship
- Director
- Issuer ticker
- TNYA
- Reported as of
- 17 Nov 2022
- Net transaction value
- +$9,998,644
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2022, 18:05:26 UTC
- Prior SEC filing
- 04 Oct 2022
- Next SEC filing
- 04 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eli Casdin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eli Casdin filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 25 Nov 2022.
Change
- Previous filing in this sequence was filed on 04 Oct 2022.
- Current net transaction value: +$9,998,644.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNYA
transaction
Common Stock
Purchase
- Transaction value
- $6,479,309
- Shares
- +2,492,042
- Change %
- +69%
- Price
- $2.60
- Shares after
- 6,078,860
- Date
- 17 Nov 2022
- Ownership
- See footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNYA
transaction
Derivative
Warrant
Purchase
- Transaction value
- $3,519,334
- Shares
- +1,354,111
- Change %
- Price
- $2.60
- Shares after
- 1,354,111
- Date
- 17 Nov 2022
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,354,111
- Exercise price
- $0.001000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Eli Casdin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The securities are owned directly by clients of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such clients and (ii) Eli Casdin, the managing member of Casdin Capital.
Footnote F2
Each Warrant will be exercisable on or after the date of issuance until the date the Warrant is exercised in full. Each Warrant will be exercisable, in the holder's discretion, by (i) payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise or (ii) a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according to a pre-set formula.
SEC remarks
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.